4578.T Otsuka Holdings Co., Ltd.
JPXHealthcareAs of 2026-08-07 15:30
Why 4578.T matters now
Otsuka Holdings Co., Ltd. (4578.T) is a Japan stock in Healthcare. The latest InvestLog snapshot shows ¥12,705.00 with +4.40% on the session and ¥6.68T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 16.54, gross margin 71.8%, and operating margin 17.3%.
Valuation
P/E (TTM)
16.54
PEG
—
P/B
2.06
P/S
2.55
EV/EBITDA
10.07
DCF Value
—
FCF Yield
4.8%
Div Yield
1.3%
Margins & Returns
Gross Margin
71.8%
Operating Margin
17.3%
Net Margin
15.5%
ROE
13.2%
ROA
9.2%
ROIC
9.5%
Listing Info
Market
Japan
Exchange
JPX
Currency
JPY
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
JP
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.